tykhr
sign in
free sign up
InVivo Therapeutics Holdings Corp
Biotechnology
Healthcare
NVIV
3.11 M shares
NASDAQ US
traded
10 Aug 2023
listed
yes
open
1.36
52 week high
9.60
high
1.37
52 week low
1.32
low
1.31
growth
-82.65 %
previous Close
1.35
P/E ratio
market cap
3.94 M
div yield
0
usd
Jun 2023
qoq
revenue
0.00 %
net incoming
-1.94 M
0.00 %
eps
0.00 %
0.00 %
eps surprise
0.00 %
net profit margin
-193700000.00 %
0.00 %
operating incoming
-2.09 M
0.00 %
net change in cash
-2.43 M
0.00 %
cash on hand
10.72 M
0.00 %
cost of revenue
0.00 %
top